These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35390147)

  • 41. Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice.
    Bolliger D; Szlam F; Suzuki N; Matsushita T; Tanaka KA
    Thromb Haemost; 2010 Jun; 103(6):1233-8. PubMed ID: 20352163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor.
    Waters EK; Genga RM; Schwartz MC; Nelson JA; Schaub RG; Olson KA; Kurz JC; McGinness KE
    Blood; 2011 May; 117(20):5514-22. PubMed ID: 21389323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequence variation data of F8 and F9 genes in functionally validated control individuals: implications on the molecular diagnosis of hemophilia.
    Seo JY; Jang MA; Kim HJ; Lee KO; Kim SH; Kim HJ
    Blood Res; 2013 Sep; 48(3):206-10. PubMed ID: 24086941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
    Sun J; Hua B; Chen X; Samulski RJ; Li C
    Hum Gene Ther; 2017 Aug; 28(8):654-666. PubMed ID: 28478688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet and endothelial expression of clotting factors for the treatment of hemophilia.
    Montgomery RR; Shi Q
    Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S46-8. PubMed ID: 22421106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
    Liu T; Scallan CD; Broze GJ; Patarroyo-White S; Pierce GF; Johnson KW
    Thromb Haemost; 2006 Jan; 95(1):68-76. PubMed ID: 16543964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New therapies using nonfactor products for patients with hemophilia and inhibitors.
    Nogami K; Shima M
    Blood; 2019 Jan; 133(5):399-406. PubMed ID: 30559263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transduction of modified factor VIII gene improves lentiviral gene therapy efficacy for hemophilia A.
    Gong J; Chung TH; Zheng J; Zheng H; Chang LJ
    J Biol Chem; 2021 Dec; 297(6):101397. PubMed ID: 34774524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V-stabilizing fab.
    Brophy DF; Martin EJ; Mohammed BM; Barrett JC; Kuhn JG; Nolte ME; Wiinberg B; Holmberg HL; Lund J; Salbo R; Waters EK
    Haemophilia; 2017 Nov; 23(6):941-947. PubMed ID: 28750471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.
    Perot E; Enjolras N; Le Quellec S; Indalecio A; Girard J; Negrier C; Dargaud Y
    Thromb Res; 2015 May; 135(5):1017-24. PubMed ID: 25795563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.
    Margaritis P; Arruda VR; Aljamali M; Camire RM; Schlachterman A; High KA
    J Clin Invest; 2004 Apr; 113(7):1025-31. PubMed ID: 15057309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
    Duncan EM; Rodgers SE; McRae SJ
    Semin Thromb Hemost; 2013 Apr; 39(3):272-82. PubMed ID: 23460037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FVIII Immunogenicity-Bioinformatic Approaches to Evaluate Inhibitor Risk in Non-severe Hemophilia A.
    Hart DP
    Front Immunol; 2020; 11():1498. PubMed ID: 32849511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antithrombin inhibition using nanobodies to correct bleeding in hemophilia.
    O'Sullivan JM; O'Donnell JS
    EMBO Mol Med; 2020 Apr; 12(4):e12143. PubMed ID: 32212299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FVIII/VWF complex displays a greater pro-haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell-based models.
    Ammollo CT; Semeraro F; Vitulli A; Dirienzo L; Mezzasoma AM; Semeraro N; Gresele P; Colucci M
    Haemophilia; 2020 Jul; 26(4):e151-e160. PubMed ID: 32325538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnosis and management of hemophilia].
    Tokugawa T
    Rinsho Ketsueki; 2020; 61(9):1338-1348. PubMed ID: 33162534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
    Milanov P; Ivanciu L; Abriss D; Quade-Lyssy P; Miesbach W; Alesci S; Tonn T; Grez M; Seifried E; Schüttrumpf J
    Blood; 2012 Jan; 119(2):602-11. PubMed ID: 22031860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic analysis for carrier diagnosis in hemophilia A and B in the Mexican population: 25 years of experience.
    González-Ramos IA; Mantilla-Capacho JM; Luna-Záizar H; Mundo-Ayala JN; Lara-Navarro IJ; Ornelas-Ricardo D; González Alcázar JÁ; Evangelista-Castro N; Jaloma-Cruz AR
    Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):939-954. PubMed ID: 33191626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.
    Díaz-Ricart M; Isola IM; Escolar G
    Drugs Today (Barc); 2018 Oct; 54(10):591-600. PubMed ID: 30398480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing.
    Lyu C; Xue F; Liu X; Liu W; Fu R; Sun T; Wu R; Zhang L; Li H; Zhang D; Yang R; Zhang L
    Haemophilia; 2016 Sep; 22(5):e427-34. PubMed ID: 27292088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.